![Baron Jean Stéphenne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Baron Jean Stéphenne
Chairman at
CUREVAC
Profile
Baron Jean Stéphenne is a Belgian businessperson who has been the head of 23 different companies. Presently, he occupies the position of Chairman of Nanocyl SA, Chairman at Parc d'aventures scientifiques SCRL, Chairman for Bone Therapeutics SA, Chairman for BePharBel Manufacturing SA, Chairman of OncoDNA SA, Chairman of Innoste SA, Chairman-Supervisory Board of CureVac NV, Chairman-Supervisory Board at CureVac AG (a subsidiary of CureVac NV), Chairman & Chief Executive Officer at Recherche Et Industrie Therapeutiques, Chairman at TiGenix NV and Chairman at Vesalius Biocapital II SA SICAR. He is also Chairman of University Foundation and President for Université Catholique de Louvain and on the board of 6 other companies. Baron Jean Stéphenne previously occupied the position of Chairman at Ion Beam Applications SA, Chairman & President for Gsk Biologicals, President at Union Wallonne des Entreprises, Chairman & President at GlaxoSmithKline Biologicals SA, Chairman of Aseptic Technologies NV, Chairman at Vesalius Biocapital I SA SICAR, Chairman at Wallon Institute for Life Lead Sciences and Chairman for BioWin ASBL. Mr. Stéphenne received an undergraduate degree from Université Catholique de Louvain and an undergraduate degree from Faculté Universitaire des Sciences Agronomiques de Gembloux.
Baron Jean Stéphenne active positions
| Companies | Position | Start |
|---|---|---|
| CUREVAC | Chairman | 2015-07-31 |
Vesalius Biocapital II SA SICAR
 Vesalius Biocapital II SA SICAR Investment ManagersFinance Acts as Venture Capital Fund | Chairman | - |
Innoste SA | Chairman | - |
N-Side SA
 N-Side SA Miscellaneous Commercial ServicesCommercial Services engages in management consulting services | Director/Board Member | 2014-12-31 |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Chairman | 2020-04-01 |
Belgian Foundation Against Cancer | Director/Board Member | - |
Université Catholique de Louvain
 Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Chairman | - |
Recherche Et Industrie Therapeutiques | Chief Executive Officer | 1973-12-31 |
Vaxxilon AG
 Vaxxilon AG BiotechnologyHealth Technology Develops and manufactures novel synthetic vaccines | Director/Board Member | - |
| ░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Baron Jean Stéphenne
| Companies | Position | End |
|---|---|---|
| ░░░ ░░░░░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░ | - |
Training of Baron Jean Stéphenne
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
36
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 36 |
|---|---|
Ion Beam Applications SA
 Ion Beam Applications SA Medical SpecialtiesHealth Technology Supplies medical, dental and hospital equipment | Health Technology |
TiGenix NV
 TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
Groupe Bruxelles Lambert SA
 Groupe Bruxelles Lambert SA Financial ConglomeratesFinance Operates as holding company whose subsidiaries which provides investment, diagnostics and outpatient, business process outsourcing & manufactures bicycles | Finance |
GlaxoSmithKline Biologicals SA
 GlaxoSmithKline Biologicals SA BiotechnologyHealth Technology Operates biopharma and pharmaceutical company | Health Technology |
IntegraGen SA
 IntegraGen SA Medical/Nursing ServicesHealth Services Develops cutting edge genome analysis products | Health Services |
BNP Paribas Fortis SA/NV
 BNP Paribas Fortis SA/NV Major BanksFinance Provides international banking services | Finance |
Faculté Universitaire des Sciences Agronomiques de Gembloux
 Faculté Universitaire des Sciences Agronomiques de Gembloux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aseptic Technologies SA
 Aseptic Technologies SA Medical SpecialtiesHealth Technology Develops and manufactures aseptic production equipment, isolator & robot lines | Health Technology |
Henogen SA
 Henogen SA Pharmaceuticals: MajorHealth Technology Develops and manufactures biopharmaceuticals | Health Technology |
Nanocyl SA
 Nanocyl SA SteelNon-Energy Minerals Specializes in manufacturing of industrial multiwall carbon nanotubes | Non-Energy Minerals |
N-Side SA
N-Side SA Miscellaneous Commercial ServicesCommercial Services engages in management consulting services | Commercial Services |
Vesalius Biocapital I SA SICAR
 Vesalius Biocapital I SA SICAR Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Opus-Invest NV
 Opus-Invest NV Construction MaterialsNon-Energy Minerals Engages in construction of prefabrication concrete elements, electricity supply and building renovation services | Non-Energy Minerals |
Union Wallonne des Entreprises
 Union Wallonne des Entreprises Miscellaneous Commercial ServicesCommercial Services Operates as a business associations | Commercial Services |
Federation of Enterprises in Belgium
 Federation of Enterprises in Belgium Miscellaneous Commercial ServicesCommercial Services Represents companies in all the three regions of belgium | Commercial Services |
BESIX Group NV
 BESIX Group NV Engineering & ConstructionIndustrial Services Provides buildings, infrastructure construction, property development and concessions services | Industrial Services |
Sparkoh CV
 Sparkoh CV Real Estate DevelopmentFinance Operates a scientific convention center | Finance |
Auguria Residential Real Estate Fund (Brussels) | |
Bone Therapeutics SA
 Bone Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops regenerative therapy products for addressing unmet medical needs in the field of bone diseases and orthopedics | Health Technology |
Wallon Institute for Life Lead Sciences | |
BioWin ASBL
 BioWin ASBL Miscellaneous Commercial ServicesCommercial Services Provides support for research and development of biomarkers | Commercial Services |
Uteron Pharma SA
 Uteron Pharma SA Electronic Equipment/InstrumentsElectronic Technology Develops controlled release devices | Electronic Technology |
Vesalius Biocapital II SA SICAR
Vesalius Biocapital II SA SICAR Investment ManagersFinance Acts as Venture Capital Fund | Finance |
University Foundation
 University Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Theravectys SAS
 Theravectys SAS BiotechnologyHealth Technology Provides biotechnology research services | Health Technology |
BePharBel Manufacturing SA
 BePharBel Manufacturing SA Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Fondation Belge Contre Le Cancer | |
OncoDNA SA
 OncoDNA SA Medical/Nursing ServicesHealth Services Develops and provides diagnosic and analytical tools for cancer treatment | Health Services |
Innoste SA | |
Vaxxilon AG
Vaxxilon AG BiotechnologyHealth Technology Develops and manufactures novel synthetic vaccines | Health Technology |
Gsk Biologicals
 Gsk Biologicals Miscellaneous Commercial ServicesCommercial Services Engages in researching, developing and manufacturing of pharmaceutical medicines, vaccines and consumer healthcare products | Commercial Services |
Belgian Foundation Against Cancer | |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
Recherche Et Industrie Therapeutiques |
- Stock Market
- Insiders
- Baron Jean Stéphenne
